Showing Results for
- Academic Journals (16)
Search Results
- 16
Academic Journals
- 16
-
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedAuthor(s): Ni Zhu aff1 , Haowen Xiao aff1 aff2 , Li-Mengmeng Wang aff1 , Shan Fu aff1 , Chan Zhao aff3 , He Huang [*] aff1 KEYWORDS genetic alterations; hematologic malignancies; protein tyrosine kinases; protein...
-
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedAuthor(s): Manuel Valladares-Ayerbes aff1 , Mar Haz-Conde aff1 , Moisés Blanco-Calvo [*] aff1 KEYWORDS cancer systems biology; high-throughput technologies; precision oncology; systems biology How many times do...
-
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedAuthor(s): Faina Linkov aff1 aff2 , Robert P Edwards aff2 , Andrew Althouse aff2 , Jose A Rauh-Hain aff3 , Marcela G Del Carmen aff3 , Kyle E Freese aff1 , Joseph L Kelley aff2 , Alexander B Olawaiye [*] aff2...
-
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedFollowing publication of the Case Report by Lorenzo Borgognoni, Leonardo Pescitelli, Carmelo Urso, Paola Brandani, Serena Sestini, Cristina Chiarugi, Riccardo Gelli, Vanni Giannotti & Gianni Gerlini, titled 'A rare case...
-
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedAuthor(s): Thomas Mehrling [*] KEYWORDS antibody-drug conjugate; chemotherapy; fusion molecule; histone-deacetylase inhibitor Chemotherapy is becoming 'smarter' specifically targeting and killing tumor cells...
-
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedAuthor(s): Samuel T Workenhe aff1 , Meghan L Verschoor aff1 , Karen L Mossman [*] aff1 KEYWORDS cancer immunotherapy; oncolytic virus Oncolytic viruses for cancer immunotherapy Depending on the type of...
-
From:Future Oncology (Vol. 11, Issue 4) Peer-Reviewed
Intratumor heterogeneity: origins, clinical significance and optimal strategies for cancer treatment
Author(s): Alberto Mangano [*] aff1 , Georgios D Lianos aff2 , Alessandro Mangano aff3 , Luigi Boni aff1 , Gianlorenzo Dionigi aff1 KEYWORDS cancer drug resistance; intertumor heterogeneity; intratumor... -
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedAuthor(s): Vito Lorusso [*] aff1 , Meinolf Karthaus aff2 , Matti Aapro aff3 KEYWORDS antiemetic; chemotherapy-induced nausea and vomiting; NEPA; netupitant; palonosetron Chemotherapy-induced nausea and vomiting...
-
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedAuthor(s): William Jacot [*] aff1 aff2 aff3 , Charles Theillet aff3 , Séverine Guiu aff1 , Pierre-Jean Lamy aff4 KEYWORDS 53BP1; BRCA1 ; breast cancer; methylation; ovarian cancer; targeted therapies Genetic...
-
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedAuthor(s): Georgios D Lianos aff1 aff2 , Alberto Mangano aff3 , William C Cho aff4 , Gianlorenzo Dionigi aff3 , Dimitrios H Roukos [*] aff1 aff2 aff5 KEYWORDS cancer; circulating tumor DNA; clonal evolution;...
-
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedAuthor(s): Yoshimitsu Kobayashi aff1 , Yoshito Komatsu [*] aff2 , Satoshi Yuki aff1 , Hiraku Fukushima aff2 , Takahide Sasaki aff1 , Ichiro Iwanaga aff3 , Minoru Uebayashi aff3 , Hiroyuki Okuda aff4 , Takaya Kusumi aff5...
-
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedAuthor(s): Luisa Foltran [*] aff1 aff2 , Giovanna De Maglio aff3 , Nicoletta Pella aff1 , Paola Ermacora aff1 , Giuseppe Aprile aff1 , Elena Masiero aff3 , Mariella Giovannoni aff1 , Emiliana Iaiza aff1 , Giovanni...
-
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedAuthor(s): Francesca Maines aff1 , Orazio Caffo [*] aff1 , Antonello Veccia aff1 , Enzo Galligioni aff1 KEYWORDS atypical metastases; castration-resistant; gastrointestinal metastases; prostate cancer Prostate...
-
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedAuthor(s): Ketty Peris [*] aff1 , Lisa Licitra aff2 , Paolo A Ascierto aff3 , Renzo Corvò aff4 , Marco Simonacci aff5 , Franco Picciotto aff6 , Giulio Gualdi aff7 , Giovanni Pellacani aff8 , Armando Santoro aff9...
-
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedAuthor(s): Juan Martin-Liberal aff1 , James Larkin [*] aff1 KEYWORDS BRAF ; chemistry; dabrafenib; ipilimumab; MAPK; MEK; melanoma; pharmacodynamics; pharmacokinetics; vemurafenib The management of malignant...
-
From:Future Oncology (Vol. 11, Issue 4) Peer-ReviewedAuthor(s): Philip A Thompson aff1 , Elizabeth J Shpall aff2 , Michael J Keating [*] aff1 KEYWORDS biology; CLL; future treatment; genetics Chronic lymphocytic leukemia (CLL) is a clonal disorder of mature...